DiarioFarma. A clinical study confirming the safety and efficacy carried out in more than 500 adult patients for 52 weeks between the Sandoz biosimilar of etanercept and Enbrel has concluded, according to the Novartis group company, that both are equivalent.
recently published
Horizon scanning
Jan 31 2024
Early Treatment: the role of biosimilars
18 2023 December
